These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16515390)

  • 1. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?
    Conn G; Kidane AG; Punshon G; Kannan RY; Hamilton G; Seifalian AM
    Expert Rev Med Devices; 2006 Mar; 3(2):245-61. PubMed ID: 16515390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of stent design and coatings on restenosis and thrombosis.
    Hara H; Nakamura M; Palmaz JC; Schwartz RS
    Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic science review: nitric oxide--releasing prosthetic materials.
    Varu VN; Tsihlis ND; Kibbe MR
    Vasc Endovascular Surg; 2009; 43(2):121-31. PubMed ID: 18799500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation with prostaglandins during extracorporeal circulation.
    Kozek-Langenecker SA
    Wien Klin Wochenschr; 1999 Feb; 111(4):129-40. PubMed ID: 10192145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug eluting stents and anticoagulation in the perioperative setting - an interdisciplinary challenge].
    Preckel B; Schlack W
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Sep; 43(9):596-601. PubMed ID: 18792862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation.
    Helft G; Gilard M; Le Feuvre C; Zaman AG
    Nat Clin Pract Cardiovasc Med; 2006 Dec; 3(12):673-80. PubMed ID: 17122800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic delivery versus elution of drugs that enhance device performance.
    Williams D
    Med Device Technol; 2005 Sep; 16(7):9, 11. PubMed ID: 16259151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [How and when to use dual antiplatelet treatment in the patient treated with oral anticoagulants?].
    Rubboli A; Di Pasquale G
    G Ital Cardiol (Rome); 2008 Nov; 9(11):745-52. PubMed ID: 19058665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radionuclides-hyaluronan-conjugate thromboresistant coatings to prevent in-stent restenosis.
    Thierry B; Winnik FM; Merhi Y; Silver J; Tabrizian M
    Biomaterials; 2004 Aug; 25(17):3895-905. PubMed ID: 15020166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
    Young JJ
    Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of heparins, oral anticoagulants, and aspirin after the year 2010.
    Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R
    Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sophisticated medical devices as local drug-delivery systems.
    Schierholz JM; Beuth J
    Med Device Technol; 2000 Mar; 11(2):12-4, 16-7. PubMed ID: 10915487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-eluting medical devices for various applications.
    Zilberman M; Elsner JJ
    J Control Release; 2008 Sep; 130(3):202-15. PubMed ID: 18687500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observance of antiplatelet therapy after stent implantation in patients under chronic oral anticoagulant treatment.
    Valencia J; Mainar V; Bordes P; Pineda J; Gómez S; Sogorb F
    J Interv Cardiol; 2008 Jun; 21(3):218-24. PubMed ID: 18422520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-eluting stents: a multidisciplinary success story.
    Burt HM; Hunter WL
    Adv Drug Deliv Rev; 2006 Jun; 58(3):350-7. PubMed ID: 16546288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance to antiplatelet substances--a real clinical problem].
    Geisler T; Gawaz M
    Herz; 2008 Jun; 33(4):260-8. PubMed ID: 18581075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombus formation at the surface of guide-wire models: effects of heparin-releasing or heparin-exposing surface coatings.
    Aldenhoff YB; Hanssen JH; Knetsch ML; Koole LH
    J Vasc Interv Radiol; 2007 Mar; 18(3):419-25. PubMed ID: 17377189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.